Acasă › Cancer (toate tipurile) › Texas › Austin
Studii clinice pentru Cancer (toate tipurile) în Austin, TX
20 studii pentru Cancer (toate tipurile) caută participanți în și în jurul orașului Austin (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
În curs de recrutareFaza 2
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
În curs de recrutareFaza 3
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
În curs de recrutareStudiu observațional
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
În curs de recrutareFaza 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
În curs de recrutareFaza 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
În curs de recrutareStudiu observațional
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
În curs de recrutareFaza 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
În curs de recrutareFaza 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
În curs de recrutareFaza 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
În curs de recrutareFaza 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
În curs de recrutareFaza 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
În curs de recrutareFaza 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
În curs de recrutareFaza 1/2
- NEXT Oncology Austin, Austin
Studii pentru Cancer (toate tipurile) în alte orașe
- Houston, TX121 studii
- New York City, NY110 studii
- Boston, MA86 studii
- Los Angeles, CA73 studii
- Nashville, TN65 studii
- Philadelphia, PA59 studii
- Durham, NC58 studii
- Washington, DC58 studii
- Chicago, IL51 studii
- Seattle, WA49 studii
- Atlanta, GA49 studii
- Arlington, VA48 studii
Alte studii în Austin
- Cancer pulmonar cu celule non-pătrate30 studii
- Obezitate20 studii
- Cancer metastatic19 studii
- Cancer colorectal19 studii
- Insuficiență cardiacă18 studii
- Cancer de sân18 studii
- Supraponderalitate18 studii
- Cancer ovarian17 studii
- Cancer endometrial15 studii
- Cancer de prostată15 studii
- Depresie14 studii
- Cancer de sân triplu negativ13 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.